Case Number 3567
Request Date 31/03/2014
Completion Date 29/04/2014

 

Details of the Request

  1. Do you measure the aggregate number of nights patients stayed in hospital longer owing to a healthcare acquired infection? If so, please provide it for the years (a) 2008/09, (b) 2009/10, (c) 2010/11, (d) 2011/12 and (e) 2012/13.
     
  2. Do you collate the total number of (a) cases and/or (b) associated deaths from (i) sepsis, (ii) septicemia, (iii) a catheter-associated urinary tract infection, (iv) a catheter-related blood infection, (v) ventilator-associated pneumonia and (vi) norovirus? If so, please provide for the above years.
     
  3. Does your Trust have a strategy for surveillance of healthcare associated infections (other than the mandatory surveillance requirements for MRSA/MSSA/Ecoli bacteraemia, C. difficile, SSI in orthopaedic surgery)? If yes, (i) what HCAI are included? and (ii) what period does the strategy cover?
     
  4. Did your Trust receive instructions in (a) 2008/09, (b) 2009/10, (c) 2010/11, (d) 2011/12 or (e) 2012/13 to reduce expenditure on infection, prevention and control?
     
  5. What strategy does your Trust have in place for the surveillance and minimisation of harm caused by infections not covered in the mandatory surveillance programme?
     
  6. Does the Trust carry out any surgical site infection surveillance that it does not report to Public Health England? If yes, please specify the protocol, the types of surgeries included and results.
     
  7. Does the Trust carry out any post discharge surgical site surveillance on any category? If yes, what are the numbers of readmission linked to surgical site infection at your Trust?
     
  8. Does the Trust carry out any financial analysis on the cost or operational impact of infections locally? If yes, please share this. If not, please could you give reasons why?
     
  9. Does the Trust carry out any post discharge surgical site surveillance on any category? If yes, what are the numbers of readmission linked to surgical site infection at your Trust?
     
  10. What surveillance systems and processes did you have for active infection control in 2012/13?
     
  11. How many staff were dedicated to the surveillance of infections and/or the analysis of that data in 2012/13?
     
  12. How many staff were on your infection prevention and control team in (a) 2008/09, (b) 2009/2010, (c) 2010/11, (d) 2011/12 and (e) 2012/13?
     
  13. What was the ratio of infection control staff (ie infection control doctors, infection control nurses, dedicated infection control surveillance auditors) to beds in Acute care at your Trust in 2012/13?
     
  14. On how many wards did you do device surveillance in 2012/13?
     
  15. On how many wards did you not do device surveillance in 2012/13?
     
  16. How many times in (a) 2008/09, (b) 2009/2010, (c) 2010/11, (d) 2011/12 and (e) 2012/13 was a member of the Board present at an infection prevention and control committee meeting?
     
  17. How many business cases were submitted by Infection Control in (a) 2008/09, (b) 2009/2010, (c) 2010/11, (d) 2011/12 and (e) 2012/13? For each year, how many of the above business cases were successful?
     
  18. What was your budget for infection prevention and control in (a) 2008/09, (b) 2009/2010, (c) 2010/11, (d) 2011/12 and (e) 2012/13?
     
  19. Do you have standardised infection control protocols and technology utilisation across all wards of the Trust?

 

Details of the Response

1. Do you measure the aggregate number of nights patients stayed in hospital longer owing to a healthcare acquired infection? If so, please provide it for the years (a) 2008/09, (b) 2009/10, (c) 2010/11, (d) 2011/12 and (e) 2012/13.

This information is not something that can be substantiated by coded data, the Trust is therefore unable to provide an answer to this question.

 

2. Do you collate the total number of : (a) cases and/or

Yes the number of cases for MRSA bacteraemia, C. diff, MSSA bacteraemias, and E. coli bacteraemias

The figures for hospital-acquired cases that we have are:

  MRSA bacteraemias C diff
2008-9 9 118
2009-10 3 53
2010-11 5 36
2011-12/td 5 19
2012-13 2 15

 

Data for E coli and MSSA is available for 2 years only

  E coli bacteraemias MSSA bacteraemias
2011-12 32 11
2012-13 26 11

 

(b) associated deaths from (i) sepsis, (ii) septicemia, (iii) a catheter-associated urinary tract infection, (iv) a catheter-related blood infection, (v) ventilator-associated pneumonia and (vi) norovirus? If so, please provide for the above years.

No – only for deaths from C. diff and E. coli bacteraemias

 

3. Does your Trust have a strategy for surveillance of healthcare associated infections (other than the mandatory surveillance requirements for MRSA/MSSA/Ecoli bacteraemia, C. difficile, SSI in orthopaedic surgery)?

Saving Lives (monthly), Hand hygiene (monthly), CAUTIs (monthly using the Safety Thermometer tool), SSI large bowel and vascular modules (every 2-3 years), ESBL/Amp C producing organisms in blood cultures from 2007-08.

 

If yes, (i) what HCAI are included?

See above

 

<p (ii) what period does the strategy cover?

From 2008 to present date

 

4. Did your Trust receive instructions in (a) 2008/09, (b) 2009/10, (c) 2010/11, (d) 2011/12 or (e) 2012/13 to reduce expenditure on infection, prevention and control?

No

 

5. What strategy does your Trust have in place for the surveillance and minimisation of harm caused by infections not covered in the mandatory surveillance programme?

Annual programme and audit and surveillance programme.

 

6. Does the Trust carry out any surgical site infection surveillance that it does not report to Public Health England? If yes, please specify the protocol, the types of surgeries included and results.

No

 

7. Does the Trust carry out any post discharge surgical site surveillance on any category? If yes, what are the numbers of readmission linked to surgical site infection at your Trust?

Yes.

  • 10/11 - 0,
  • 11/12 - 0,
  • 12/13 - 2,
  • 13/14 - 1.

8. Does the Trust carry out any financial analysis on the cost or operational impact of infections locally? If yes, please share this. If not, please could you give reasons why?

No

 

9. Does the Trust carry out any post discharge surgical site surveillance on any category? If yes, what are the numbers of readmission linked to surgical site infection at your Trust?

Same as Question 7.

 

10. What surveillance systems and processes did you have for active infection control in 2012/13?

SISS, Data Capture system and WinPath, Real Time and Bluespier.

 

11. How many staff were dedicated to the surveillance of infections and/or the analysis of that data in 2012/13?

4

 

12. How many staff were on your infection prevention and control team in

  • 2008/09 - 4
  • 2009/10 - 5
  • 2010/11 - 4
  • 2011/12 - 4
  • 2012/13 - 4

 

13. What was the ratio of infection control staff (ie infection control doctors, infection control nurses, dedicated infection control surveillance auditors) to beds in Acute care at your Trust in 2012/13?

4:550 beds

 

14. On how many wards did you do device surveillance in 2012/13?

All wards

 

15. On how many wards did you not do device surveillance in 2012/13?

None

 

16. How many times in was a member of the Board present at an infection prevention and control committee meeting?

  • 2008/09 - 1
  • 2009/10 - 2
  • 2010/11 - 0 (1 representative),
  • 2011/12 - 1
  • 2012/13 - 2

 

17. How many business cases were submitted by Infection Control in (a) 2008/09, (b) 2009/2010, (c) 2010/11, (d) 2011/12 and (e) 2012/13? For each year, how many of the above business cases were successful?

None

 

18. What was your budget for infection prevention and control in

  • 2008/09 - 106,473
  • 2009/10 - 73,497
  • 2010/11 - 137,912
  • 2011/12 - 121,976
  • 2012/13 - 124,692

 

19. Do you have standardised infection control protocols and technology utilisation across all wards of the Trust?

Yes

 

Further Question

Can you please provide a figure for Question 14.

 

Further Response

In answer to your query regarding question 14:

22 wards:- 1 paediatric ward and 21 adult wards.